Health Canada issues stronger warnings for blood thinner Pradaxa
Posted: March 28, 2012
Pharmaceutical
Health regulators in Canada have issued a warning on the new blood thinner Pradaxa, sold in Canada as Pradax. The new safety label will warn that the risk of internal bleeding events may be increased among patients with kidney problems,
Pinnacle recipient’s on-camera revision surgery reveals extensive injuries
Posted: March 27, 2012
Pharmaceutical
Maureen Bayles, a resident of Richmond, England, just to the west of London, told the British Broadcasting Corporation’s (BBC) Newsnight program that when she had to get her hips replaced in 2005, she was told that DePuy’s Pinnacle implants were
DePuy ordered phase-out of defective hip implant after FDA inquiry
Posted: March 23, 2012
Pharmaceutical
Johnson & Johnson decided to phase out one of the hip implants made by its subsidiary DePuy Orthopaedics and sell off its inventory shortly after receiving an inquiry from the Food and Drug Administration (FDA) that questioned the device’s safety
Johnson & Johnson sold unapproved transvaginal mesh for years, report claims
Posted: March 23, 2012
Pharmaceutical
Johnson & Johnson sold its Gynecare Prolift vaginal mesh for three years without obtaining approval for the product, according to a March 21 report by Bloomberg. The Prolift mesh, which the U.S. Food and Drug Administration (FDA) eventually approved for
Consumer Reports warns of FDA’s fast-track medical device approval process
Posted: March 21, 2012
Pharmaceutical
In an email blast to one million subscribers, Consumer Reports President Jim Guest wrote that medical devices that receive U.S. Food and Drug Administration (FDA) approval through its fast-track process have created a “nightmare scenario” for public safety. The fast-track
BA lawyer appointed to help manage Actos bladder cancer litigation
Posted: March 20, 2012
Pharmaceutical
Nineteen plaintiffs attorneys, including Beasley Allen attorney Andy Birchfield, have been appointed to manage litigation involving claims that Takeda Pharmaceuticals Co.’s type 2 diabetes drug Actos causes bladder cancer. Takeda, Asia’s largest drug maker, may face as many as 10,000
New Zealanders who say they were injured by DePuy hip implants find hope in UK litigation
Posted: March 19, 2012
Pharmaceutical
A group of New Zealanders allegedly harmed by metal-on-metal hip implants manufactured by DePuy Orthopaedics is joining an international lawsuit against the company.
Judge OKs sale of generic Paxil despite risk for birth defects
Posted: March 16, 2012
Pharmaceutical
A U.S. judge has ruled that GlaxoSmithKline Plc (GSK) can sell a generic copy of its Paxil CR antidepressant to Apotex Inc., denying a bid from generic drug company Mylan to block the sale. Mylan signed a two-year agreement in
DePuy hip implant leads to renewed pain, hardship for Minnesota woman
Posted: March 14, 2012
Pharmaceutical
Terri, a mother of twin college-age daughters and a grown son, told the Minnesota StarTribune that the DePuy ASR artificial hip she received in 2008 to counter the chronic arthritis in her right hip gave her a new lease on
Researchers warn doctors not to use metal-on-metal hip implants
Posted: March 13, 2012
Pharmaceutical
Researchers who conducted studies on metal-on-metal hip implants are asking doctors to stop using the devices because they believe they are much more likely to need repair or replacement, and may leech toxic metals into patients’ bloodstreams. The study, funded
